A brief motivational intervention for substance misuse in recent-onset psychosis

Drug and Alcohol Review
D J KavanaghAnne Clair

Abstract

Substance misuse is common in early psychosis, and impacts negatively on outcomes. Little is known about effective interventions for this population. We report a pilot study of brief intervention for substance misuse in early psychosis (Start Over and Survive: SOS), comparing it with Standard Care (SC). Twenty-five in-patients aged 18-35 years with early psychosis and current misuse of non-opioid drugs were allocated randomly to conditions. Substance use and related problems were assessed at baseline, 6 weeks and 3, 6 and 12 months. Final assessments were blind to condition. All 13 SOS participants who proceeded to motivational interviewing reported less substance use at 6 months, compared with 58% (7/12) in SC alone. Effects were well maintained to 12 months. However, more SOS participants lived with a relative or partner, and this also was associated with better outcomes. Engagement remained challenging: 39% (16/41) declined participation and 38% (5/13) in SOS only received rapport building. Further research will increase sample size, and address both engagement and potential confounds.

References

Jan 1, 1986·Schizophrenia Bulletin·D LukoffK H Nuechterlein
Mar 1, 1993·Addiction·T H BienJ S Tonigan
May 2, 2000·The Australian and New Zealand Journal of Psychiatry·D J KavanaghG Hamilton
Jul 29, 2000·The American Journal on Addictions·S MartinoB J Rounsaville
Aug 30, 2000·Journal of Substance Abuse Treatment·K B CareyJ S Simons
Oct 7, 2000·Journal of Studies on Alcohol·S DaweD Kavanagh

❮ Previous
Next ❯

Citations

Mar 19, 2009·Social Psychiatry and Psychiatric Epidemiology·Sophia EberhardAgneta Ojehagen
Aug 16, 2005·Current Psychiatry Reports·Robert M RothAlan I Green
Dec 9, 2009·Journal of Consulting and Clinical Psychology·Clara M BradizzaNicole D Mercer
Mar 6, 2007·Schizophrenia Bulletin·Suzanne ArchieRobert B Zipursky
Dec 4, 2009·Schizophrenia Bulletin·Lisa B DixonUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Jun 8, 2006·The Australian and New Zealand Journal of Psychiatry·David SchofieldGail Brennan
Sep 9, 2011·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Tricia NagelCarolyn Griffin
May 20, 2015·Journal of Mental Health·Sophia EberhardAgneta Öjehagen
Jun 5, 2007·Addictive Behaviors·Bob GreenRoss McD Young
Jul 5, 2005·Acta Psychiatrica Scandinavica·M LambertB G Schimmelmann
Mar 16, 2007·Acta Psychiatrica Scandinavica·J Addington, D Addington
Jul 25, 2013·Early Intervention in Psychiatry·Shane RebgetzMartin Lambert
Apr 7, 2009·Addictive Behaviors·David J Kavanagh, Jennifer M Connolly
Nov 22, 2005·Schizophrenia Research·Darryl WadePatrick D McGorry
Apr 14, 2016·Schizophrenia Research·Shane RebgetzLeanne Hides
Jan 17, 2012·Psychiatric Rehabilitation Journal·Ashli J SheidowMaryann Davis
Dec 15, 2010·Drug and Alcohol Dependence·R Morgan WainSteven Lovett
Sep 14, 2007·European Addiction Research·Luis SanJose Martinez-Raga
Jun 3, 2016·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Cristina AydinZenovia Ursuliak
Feb 26, 2010·The Australian and New Zealand Journal of Psychiatry·Stanley V CattsRussell W Evans
Sep 14, 2007·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Rosalind KempThiagarajan Sitharthan
May 28, 2005·Journal of Psychiatric Practice·Beverley RaphaelJason Connor
Mar 21, 2009·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·Peter Tucker
May 13, 2011·The Cochrane Database of Systematic Reviews·Geir SmedslundKjetil Karlsen
Sep 29, 2018·Journal of Dual Diagnosis·Lauren E ReevesGary Epstein-Lubow
Oct 5, 2013·The Cochrane Database of Systematic Reviews·Glenn E HuntMichelle Cleary
Dec 13, 2019·The Cochrane Database of Systematic Reviews·Glenn E HuntMichelle Cleary
Jun 17, 2011·The Cochrane Database of Systematic Reviews·John BolaHaluk Soydan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.